Labib A, Lenaerts V, Chouinard F, Leroux J C, Ouellet R, van Lier J E
Groupe CRM en Sciences des Radiations, Faculté de médecine, Université de Sherbrooke, Québec, Canada.
Pharm Res. 1991 Aug;8(8):1027-31. doi: 10.1023/a:1015809124895.
Preparation methods of cyanoacrylic nanocapsules or nanoparticles containing phthalocyanines and naphthalocyanines are described. Nanocapsules were obtained by interfacial polymerization in an oil-in-water emulsion. Drug encapsulation efficiency depended upon drug concentration, ethanol concentration, and phthalocyanine sulfonation degree and reached 100% in some cases. Nanocapsules size ranged from 150 to 250 nm and varied with phthalocyanine sulfonation degree and pH of the aqueous phase. Nanoparticles were prepared by the addition of monomer to an aqueous phase containing hydrophilic phthalocyanine derivatives. Depending upon the pH, sizes ranged from 10 to 380 nm. Drug binding was between 75 and 80%. These new preparations could prove useful in the photodynamic treatment of tumors.
描述了含酞菁和萘酞菁的氰基丙烯酸纳米胶囊或纳米颗粒的制备方法。纳米胶囊通过水包油乳液中的界面聚合获得。药物包封效率取决于药物浓度、乙醇浓度和酞菁磺化程度,在某些情况下可达100%。纳米胶囊尺寸范围为150至250nm,并随酞菁磺化程度和水相pH值而变化。纳米颗粒通过将单体添加到含有亲水性酞菁衍生物的水相中制备。根据pH值,尺寸范围为10至380nm。药物结合率在75%至80%之间。这些新制剂可能在肿瘤的光动力治疗中证明是有用的。